losartan has been researched along with Cushing's Syndrome in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Excerpt | Relevance | Reference |
|---|---|---|
| "Losartan treatment resulted in stimulation of active renin and decrease of plasma and urinary kallikrein activity." | 6.69 | Losartan in Cushing's syndrome. ( Andrewa, M; Angelova-Gateva, P; Natchev, E; Orbetzova, M; Torbova, S; Tzingilev, D; Vergilova, J; Wipperrnann, M; Zacharieva, S, 1998) |
| "Losartan treatment resulted in stimulation of active renin and decrease of plasma and urinary kallikrein activity." | 2.69 | Losartan in Cushing's syndrome. ( Andrewa, M; Angelova-Gateva, P; Natchev, E; Orbetzova, M; Torbova, S; Tzingilev, D; Vergilova, J; Wipperrnann, M; Zacharieva, S, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zacharieva, S | 1 |
| Orbetzova, M | 1 |
| Natchev, E | 1 |
| Vergilova, J | 1 |
| Andrewa, M | 1 |
| Wipperrnann, M | 1 |
| Torbova, S | 1 |
| Tzingilev, D | 1 |
| Angelova-Gateva, P | 1 |
1 trial available for losartan and Cushing's Syndrome
| Article | Year |
|---|---|
Losartan in Cushing's syndrome.
Topics: Administration, Oral; Antihypertensive Agents; Cushing Syndrome; Humans; Hypertension; Kallikrein-Ki | 1998 |